Quick Answer ABBOTT LABORATORIES reported Total Assets of $86.71 billion for fiscal year 2025. ABBOTT LABORATORIES Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $86.71B +6.5% 2024 $81.41B +11.2% 2023 $73.21B -1.6% 2022 $74.44B -1.0% 2021 $75.20B +3.6% 2020 $72.55B +6.9% 2019 $67.89B +1.1% 2018 $67.17B -11.9% 2017 $76.25B +44.8% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported Diluted EPS of $3.72 per share for fiscal year 2025. ABBOTT LABORATORIES Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $3.72 -51.3% 2024 $7.64 +134.4% 2023 $3.26 -16.6% 2022 $3.91 -0.8% 2021 $3.94 +57.6% 2020 $2.50 +21.4% 2019 $2.06 +54.9% 2018 $1.33 +392.6% 2017 $0.27 -71.3% … Read more
Quick Answer ABBOTT LABORATORIES reported Revenue (ASC 606) of $44.33 billion for fiscal year 2025. ABBOTT LABORATORIES Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $44.33B +5.7% 2024 $41.95B +4.6% 2023 $40.11B -8.1% 2022 $43.65B +1.3% 2021 $43.08B +24.5% 2020 $34.61B +8.5% 2019 $31.90B +4.3% 2018 $30.58B +11.6% 2017 … Read more
Quick Answer ABBOTT LABORATORIES reported Net Income of $6.52 billion for fiscal year 2025. ABBOTT LABORATORIES Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $6.52B -51.3% 2024 $13.40B +134.2% 2023 $5.72B -17.5% 2022 $6.93B -2.0% 2021 $7.07B +57.3% 2020 $4.50B +21.9% 2019 $3.69B +55.7% 2018 $2.37B +396.4% 2017 $477.00M -65.9% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported Total Revenue of $44.33 billion for fiscal year 2025. ABBOTT LABORATORIES Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $44.33B +5.7% 2024 $41.95B +4.6% 2023 $40.11B -8.1% 2022 $43.65B +1.3% 2021 $43.08B +24.5% 2020 $34.61B +8.5% 2019 $31.90B +4.3% 2018 $30.58B +11.6% 2017 $27.39B +31.3% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported Total Revenue of $44.33 billion for fiscal year 2025. ABBOTT LABORATORIES — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $44.33B+5.7% $41.95B+4.6% $40.11B-8.1% $43.65B+1.3% $43.08B+24.5% $34.61B+8.5% Revenue (ASC 606) $44.33B+5.7% $41.95B+4.6% $40.11B-8.1% $43.65B+1.3% $43.08B+24.5% $34.61B+8.5% Net Income $6.52B-51.3% $13.40B+134.2% $5.72B-17.5% $6.93B-2.0% $7.07B+57.3% $4.50B+21.9% Diluted EPS … Read more
Quick Answer Absci Corp reported Shares Outstanding of 115.36 million shares for fiscal year 2024. Absci Corp Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 115.36M +23.9% 2023 93.09M +0.7% 2022 92.41M -0.3% 2021 92.65M +417.9% 2020 17.89M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2024 … Read more
Quick Answer Absci Corp reported Operating Income of -$120.32 million for fiscal year 2025. Absci Corp Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$120.32M -10.5% 2024 -$108.89M +5.7% 2023 -$115.52M -8.2% 2022 -$106.75M -41.9% 2021 -$75.24M -465.7% 2020 -$13.30M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September … Read more
Quick Answer Absci Corp reported R&D Expense of $81.42 million for fiscal year 2025. Absci Corp R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $81.42M +27.5% 2024 $63.86M +32.9% 2023 $48.07M -18.4% 2022 $58.91M +32.1% 2021 $44.59M +289.5% 2020 $11.45M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September … Read more
Quick Answer Absci Corp reported Stockholders Equity of $189.45 million for fiscal year 2025. Absci Corp Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $189.45M +5.8% 2024 $179.13M +1.7% 2023 $176.18M -35.8% 2022 $274.41M -25.0% 2021 $366.11M +509.4% 2020 -$89.43M -117.3% 2019 -$41.16M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity … Read more